// App-Quantinova.ai

EP498 : CD19 CAR-T IN LESS FIT PATIENTS WITH R/R HIGH-GRADE LYMPHOMA

Researchers

Presenter

  • Andrea Kuhnl

Principal Investigators

  • Claire Roddie

  • Tobias Menne

  • Eleni Tholouli

  • Amit Patel

  • Caroline Besley

  • Sridhar Chaganti

  • Wendy Osborne

  • Jane Norman

  • Kirsty Sharplin

  • Maria Cuadrado

  • Lorna Neill

  • Anne-Louise Latif

  • Carlos Arias

  • Ceri Jones

  • Ben Uttenthal

  • Andrew McMillan

  • Rod Johnson

  • Robin Sanderson

  • William Townsend

Medical Centers

  • Kings College London, London, United Kingdom

  • Queen Elizabeth University Hospital, Glasgow, United Kingdom

  • Bristol University, Bristol, United Kingdom.

  • The Christie Manchester,Manchester,United Kingdom

  • Addenbrookes Hospital, Cambridge, United Kingdom

  • Nottingham City Hospital, Nottingham, United Kingdom

  • St James Hospital, Leeds, United Kingdom

  • Kings College London, London, United Kingdom

  • Freeman Hospital, Newcastle upon Tyne, United Kingdom

  • Queen Elizabeth Hospital, Birmingham, United Kingdom

  • Cardiff University, Velindre Hospital, Cardiff, United Kingdom

  • Kings College London, London, United Kingdom

  • Manchester Royal Infirmary, Manchester, United Kingdom

  • The Royal Marsden Hospital, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lymphomas

Biomarkers

  • Cluster of Differentiation 19

Drug/Treatment

  • Axicabtagene ciloleucel

  • tisagenlecleucel-t

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved